Procurement comparison
Linear vs fragment SPPS for GLP-1 peptides
Fragment-based synthesis approaches divide a long peptide into smaller segments that are synthesized separately and then joined through a conjugation step. In theory, shorter fragments can be produced with higher yields. However, fragment strategies introduce
Review the documented criteria directly; this page does not generate a winner or rating.
- Fragment-based synthesis approaches divide a long peptide into smaller segments that are synthesized separately and then joined through a conjugation step. In theory, shorter fragments can be produced with higher yields.
- However, fragment strategies introduce additional operations, including:
- Soft cleavage of fragments
- Conjugation reactions
- Additional analytical development
- Fragment conjugation can also introduce epimerization , producing stereoisomers that may be difficult to remove during purification.
- Because of these trade-offs, the optimal strategy depends strongly on the specific molecule and manufacturing conditions.
- In a recent evaluation of a representative GLP-1 receptor agonist, we compared optimized linear SPPS with fragment-based routes under realistic manufacturing assumptions.
- The study highlighted an important finding:
- At high per-cycle SPPS yields, linear synthesis can outperform fragment-based approaches, delivering higher overall yields, and simpler, more cost efficient manufacturing processes.
- This does not mean fragment synthesis is ineffective. For very long peptides or molecules with favorable conjugation sites, fragment approaches may still offer advantages.
- However, the results demonstrate that high-efficiency linear SPPS remains highly competitive for GLP-1-like peptides.
- For a deeper discussion of the study design and findings, see our full GLP-1 receptor agonist feasibility study on linear vs fragment SPPS.